NewEdge Wealth’s Repare Therapeutics RPTX Stock Holding History

NewEdge Wealth’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-32,959	Closed	-$85.7K	–	1264
2025 Q4	$85.7K	Hold	32,959	–	–	﹤0.01%	1178
2025 Q3	$57K	Hold	32,959	–	–	﹤0.01%	1012
2025 Q2	$50.1K	Buy	+32,959	New	+$43K	﹤0.01%	954

NewEdge Wealth's RPTX Position: Q1 2026 in Review

NewEdge Wealth sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 32,959 shares — an estimated $85.7K sold.

NewEdge Wealth first reported a position in RPTX in Q2 2025 and held it in 3 quarters. The position peaked at $85.7K in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

NewEdge Wealth reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
NewEdge Wealth sold 32,959 Repare Therapeutics shares in Q1 2026, an estimated $85.7K.
NewEdge Wealth first reported a position in Repare Therapeutics in Q2 2025 and held it in 3 quarters.
NewEdge Wealth's Repare Therapeutics position peaked at $85.7K in Q4 2025.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.